CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 25, 2022 |
Chief Operating Officer
Trans History: 24
|
Chief Operating Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $13.23 | 204,805 |
| May 15, 2024 |
Director
Trans History: 1
|
Director | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Feb 16, 2024 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 96,328 |
| Feb 16, 2024 |
Director
Trans History: 26
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 161,908 |
| Feb 16, 2024 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 80,671 |
| Feb 16, 2024 |
Director
Trans History: 57
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 93,506 |
| Feb 16, 2024 |
Director
Trans History: 22
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 111,936 |
| Feb 16, 2024 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 46,925 |
| Feb 16, 2024 |
Director
Trans History: 7
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 70,943 |
| Feb 16, 2024 |
Director
Trans History: 98
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 100,298 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.